Build status - In Progress

Evaluation of Vascular Health Profile in Predicting Venous Thromboembolism

Evaluation of Vascular Health Profile in Predicting Venous Thromboembolism
Recruiting
1 years - 99 years
All
100 participants needed
1 Location

Brief description of study

The main goal of this study is to utilize previously validated cytometric markers of to identify cancer patients at high risk of VTE. The primary outcome will be DVT or pulmonary embolism (PE). Patients with pancreatic and brain cancer will be enrolled as these patients are known to have higher rates of VTE relative to other forms of cancer. Patients will receive a screening duplex ultrasound, interval 3 month ultrasound for asymptomatic DVT and will be followed longitudinally for one year. Blood will be collected during the initial screening, at the three month interval follow-up (at time of second ultrasound) and any VTE event over the course of the year for cytometric analysis and MP TF activity.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Pancreatic Neoplasms
  • Age: 1 years - 99 years
  • Gender: All
Updated on 04 Aug 2024. Study ID: 820651

Find a site

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact
Race
Ethnicity
Other language

Interested in the study

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center